Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence

Volume 19, Issue 3, December 2023 .

Source: Human Vaccines and Immunotherapeutics - November 15, 2023 Category: Allergy & Immunology Authors: Raunak ParikhDavid SingerElizabeth Chmielewski-YeeChristophe Dessarta Global Medical Affairs, GSK, Wavre, Belgiumb US Health Outcomes and Epidemiology, GSK, Philadelphia, PA, USAc Epidemiology and Patient Centered Outcomes, GSK, Rockville, MD, USAd Clinic Source Type: research